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Abstract
Max-E47 is a protein chimera generated from the fusion of the DNA-binding basic region of Max and the dimerization
region of E47, both members of the basic region/helix-loop-helix (bHLH) superfamily of transcription factors. Like native
Max, Max-E47 binds with high affinity and specificity to the E-box site, 59-CACGTG, both in vivo and in vitro. We have
determined the crystal structure of Max-E47 at 1.7 A ˚ resolution, and found that it associates to form a well-structured dimer
even in the absence of its cognate DNA. Analytical ultracentrifugation confirms that Max-E47 is dimeric even at low
micromolar concentrations, indicating that the Max-E47 dimer is stable in the absence of DNA. Circular dichroism analysis
demonstrates that both non-specific DNA and the E-box site induce similar levels of helical secondary structure in Max-E47.
These results suggest that Max-E47 may bind to the E-box following the two-step mechanism proposed for other bHLH
proteins. In this mechanism, a rapid step where protein binds to DNA without sequence specificity is followed by a slow
step where specific protein:DNA interactions are fine-tuned, leading to sequence-specific recognition. Collectively, these
results show that the designed Max-E47 protein chimera behaves both structurally and functionally like its native
counterparts.
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Introduction
The basic helix-loop-helix (bHLH) proteins are a widely dis-
tributed superfamily of transcription factors that regulate genes
important for cell proliferation, differentiation and apoptosis [1].
These transcription factors comprise an N-terminal basic region
(b) necessary for binding to a shared signature DNA-motif
(
59CANNTG) and a C-terminal helix-loop-helix (HLH) region
that mediates homo- or heterodimerization [2,3]. Some members
of the bHLH superfamily include additional structural motifs, such
as the bHLHZ family that contains a C-terminal leucine zipper (Z)
or the bHLHPAS family that includes a Per-Arnt-Sim (PAS)
domain adjacent to the helix-loop-helix region.
The Myc oncoprotein is likely the best-studied member of the
bHLHZ family. In response to cellular signals, Myc regulates
many processes, including cell proliferation, growth and transfor-
mation, whereas deregulated expression of Myc increases
apoptosis, genomic instability and angiogenesis [4]. Activation
by Myc requires heterodimerization with Max, a bHLHZ
transcription factor that serves to regulate other members of this
superfamily [5,6,7]. In the absence of Max, Myc is incapable of
binding to its target DNA sequence (
59CACGTG), known as the
Enhancer-box (E-box). Conversely, Max readily homodimerizes
and binds the E-box with high affinity [7]. Max also forms
heterodimers with other bHLHZ proteins, including the Mad1
transcription factor. The Mad1/Max complex functions as a
transcriptional repressor [8,9,10,11] and, thus, it has been
suggested that Myc/Max and Mad/Max complexes define a
molecular switch regulating the cellular transition from a growth
to a resting state.
Several crystal structures of bHLHZ proteins bound to their
cognate E-boxes have been determined [12,13,14,15,16,17].
While biochemical studies had originally proposed that binding
of bHLHZ proteins to the E-box imposed significant bending of
the DNA, the crystal structures revealed that bHLHZ proteins
either do not bend or only mildly bend DNA. Remarkably, the
conformations of all bHLHZ complexes solved to date are
virtually identical, revealing the high structural conservation
within this family of proteins. The basic region, responsible for
DNA binding, defines the N-terminus of the first a-helix and in the
absence of DNA. This helix is presumably unfolded, but becomes
structured upon binding to its target DNA sequence [18,19]. The
helix-loop-helix subdomain forms a four-helix bundle that is
responsible for dimer formation and specification of dimerization
partners. In the structure of wild-type Max bound to DNA, the
leucine zipper following the helix-loop-helix subdomain is not well
defined, suggesting that this motif improves partner specificity
rather than strengthening dimerization per se [12]. Comparison of
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not Myc, can form both homo- and heterodimers [17].
Since the biological functions of Myc depend on the Myc/Max/
Mad network [20], regulating the interaction of Myc with its
binding partner Max has become an attractive therapeutic target.
Omomyc, a variant of Myc encompassing four point mutations
within its leucine zipper, interacts with Myc. These Myc/
Omomyc heterodimers do not bind DNA, but sequester Myc
into inactive complexes [21]. The positive effects associated with
introducing Omomyc in a Myc-induced tumorigenesis mouse
model are dependent on the presence of oncogenic Myc,
supporting the idea that sequestration of Myc is of therapeutic
value [22]. In recent years, an alternative dominant negative
strategy using minimalist proteins designed to block binding of the
Myc/Max complex to the E-box has been devised. One of these
proteins, Max-E47, encompasses the basic region of Max and the
helix-loop-helix of E47, which is also a member of the bHLH
superfamily but does not possess a leucine zipper [23]. Like Max,
E47 forms homo- and heterodimers with other bHLHZ proteins
[3]. The Max-E47 chimera binds to E-box DNA with affinity
similar to the Max homodimer and outcompetes Max binding to
the E-box in the yeast one-hybrid assay [23].
We have solved the crystal structure of the Max-E47 ho-
modimer and characterized its oligomeric state. The basic region
of Max-E47 forms an a-helix that closely resembles the
conformation seen in other Max bHLHZ structures bound to
DNA, suggesting that Max-E47 forms a structured dimer in the
absence of DNA. Accordingly, Max-E47 monomers were not
detected by analytical ultracentrifugation, even at low micromolar
concentrations, demonstrating that Max-E47 exists predominantly
as a dimer in solution. Circular dichroism analysis revealed that
Max-E47 becomes more ordered upon DNA binding, suggesting
that the basic region of the protein becomes stabilized in a helical
conformation upon DNA binding or at increasing protein
concentrations. Similar to the bHLHZ transcription factor USF
[24], Max-E47 becomes more ordered whether in the presence of
specific E-box DNA or nonspecific DNA, indicating that it may
also follow a two-step binding mechanism, wherein a rapid and
non-specific association with DNA is followed by a slow
conformational change induced by E-box recognition.
Materials and Methods
Protein Expression and Purification
The Max-E47 hybrid was designed as described earlier [23]. In
brief, Max-E47 was generated by fusing the DNA binding basic
region of Max (residues 22 to 36) to the helix-loop-helix di-
merization region of E47 (residues 349 to 400) and subcloned into
the pET28a(+) vector using the NcoI and XhoI restriction sites.
For protein overproduction, BL21(DE3) cells were transformed
with the plasmid encoding Max-E47 (pAG8349) and grown in the
presence of kanamycin (100 mg/mL) to an OD600 of approxi-
mately 0.7 at 37uC with orbital agitation. The cultures were then
chilled on ice with agitation, and protein over-production was
induced by addition of 0.1 mM IPTG. The cells were grown for
5 hours at 25uC with agitation and subsequently harvested by
centrifugation at 5,000 g for 10 minutes. Cell pellets were washed
with ice-cold phosphate buffered saline and stored at 280uC. The
two cloning variants of Max-E47, Max-E47Y and Max-E47YF
(pAG8474 and pAG8475, respectively) [23], were produced in a
similar manner.
Max-E47, Max-E47Y and Max-E47YF were found in the
insoluble fraction of the cell lysates and, hence, all purification
steps were conducted under denaturing conditions at room
temperature. Cells pellets were resuspended in 20 mL per liter
of cells in buffer A (20 mM Tris pH 8, 0.3 M NaCl, 10 mM 2-
mercaptoethanol, 10% (v/v) glycerol, 8 M urea and 0.03 M
imidazole) supplemented with 25 mL lauryldimethylamine oxide
(LDAO) and a cocktail of protease inhibitors containing 1 mM
PMSF, 0.7 mg/mL Pepstatin A, 5 mg/mL leupeptin and 1 mM
benzamidine. Cells were lysed by sonication and the lysate cleared
by centrifugation at 40,000 g for 40 minutes. The supernatant was
collected, filtered and loaded onto a HiTrap Ni-affinity column
(GE Healthcare) pre-equilibrated with buffer A. The column was
washed with buffer A supplemented with 0.06 M imidazole to
remove contaminants bound to the column and Max-E47 was
subsequently eluted with buffer A containing 0.3 M imidazole.
Protein refolding
Max-E47 was refolded by a combination of dilution and dialysis
to remove urea. Fractions containing Max-E47 were pooled after
collection from the HiTrap Ni-affinity column and diluted into
buffer B (20 mM Tris pH 8, 0.3 M NaCl, 10 mM 2-mercapto-
ethanol and 10% (v/v) glycerol) to a final concentration of 1 M
urea and dialyzed against buffer B containing 1 M urea for
3 hours at room temperature. This sample was subsequently
dialyzed against buffer B containing 0.5 M urea and against buffer
B containing 0.25 M urea at 4uC overnight. The refolded sample
was then allowed to reach room temperature and loaded on an
SP-Sepharose column (GE Healthcare) pre-equilibrated with
buffer C (20 mM Tris pH 8, 0.1 M NaCl, 10 mM 2-mercapto-
ethanol and 10% (v/v) glycerol). Max-E47 was eluted from the
column using a step gradient from 0.1–1 M NaCl (Max-E47 elutes
at 0.6 M NaCl). Protein containing fractions were pooled and
concentrated to 3 mg/mL in storage buffer (10 mM Tris pH 8,
0.1 M NaCl, 5 mM 2-mercaptoethanol and 5% (v/v) glycerol).
The oligomeric state of the protein was assessed by size-exclusion
chromatography using a Superdex-75 column (GE Healthcare)
and the lack of aggregates was confirmed by dynamic light
scattering on a Nano-S Zetasizer (Spectra Research Corporation)
using a 12 mL cuvette. In contrast to Max-E47, the Max-E47Y
and Max-E47YF variants had to be stored at room temperature to
prevent protein aggregation.
Crystallization, Data Collection, Structure Determination
and Refinement
Initial crystals were obtained with the sparse matrix anions suite
(Qiagen) using the vapor diffusion method on sitting drops.
Optimal crystals grew in 0.1 M sodium acetate anhydrous pH 4.6,
3.2–3.5 M sodium nitrate and 5% glycerol at 4uC and reached
their maximum size in one to three weeks. Prior to flash-freezing
them in liquid nitrogen, crystals were cryo-protected by addition of
25% (v/v) glycerol to the crystallization solution.
A complete data set was collected at the 625 beam line in
NSLS, Brookhaven National Laboratory (Upton, NY). Data were
indexed, processed and merged using HKL2000 [25]. The initial
phases were determined by molecular replacement using PHA-
SER [26] and the E47 monomer as searching model (PDB ID:
2QL2, [16]). The final structure was obtained by alternating cycles
of manual building in COOT with refinement in phenix.refine
using TLS [27,28]. The final model has 96.4% of residues in most
favored regions, and none in the disallowed regions of the
Ramachandran plot as judged by MolProbity [29]. Accessible
surface areas were calculated using the areaimol program in CCP4
with a solvent probe radius of 1.4 A ˚ [30]. Atomic coordinates and
structure factors of Max-E47 have been deposited in the Protein
Data Bank under accession code 3U5V.
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To remove protein aggregates due to freezing and thawing
of the sample, as well as to exchange the buffer prior to
analytical ultracentrifugation, samples of Max-E47 or Max-
E47YF were purified by size-exclusion chromatography using a
Superdex75 column (GE Healthcare) pre-equilibrated with
ultracentrifugation buffer (20 mM Tris pH 8.0, 0.15 M NaCl
and 10 mM 2-mercaptoethanol). Sedimentation velocity exper-
iments, as well as sedimentation equilibrium experiments, on
Max-E47 were carried out in ultracentrifugation buffer. To
remove remaining traces of glycerol, the protein eluted from the
Superdex75 column was loaded a second time onto the
Superdex75 column.
Sedimentation velocity experiments were conducted at 20.0uC
on a Beckman Coulter ProteomeLab XL-I analytical ultracentri-
fuge. 400 mL of each of the samples at various concentrations were
loaded into 2-channel centerpiece cells, allowed to equilibrate at
20.0uC under vacuum for at least 4 hours and subsequently
analyzed at 50,000 rpm over a period of 12 hours. Scans were
collected using the Rayleigh interference optical detection system
at seven-minute intervals. Data were analyzed in SEDFIT 12.1b
[31] in terms of a continuous c(s) distribution of Lamm equation
solutions using an uncorrected s range of 0.0–5.0 S with a
resolution of 100 and a confidence level of 0.68. In all cases,
excellent fits were obtained with interference root mean square
deviations values ranging from 0.002–0.005 fringes. Solution
densities r, viscosities g and protein partial specific volumes v were
calculated in SEDNTERP 1.09 [32]. In the case of buffers
containing 5% (v/v) glycerol, solution densities were measured
experimentally at 20.0uC on a Mettler-Toledo DE51 density
meter; the exact glycerol concentration was thus determined and
the corresponding viscosity calculated in SEDNTERP 1.09.
Sedimentation coefficients s were corrected to s20,w. Interference
signal increments eJ, used for the estimation of sample concentra-
tions, were calculated using eJ=(M/1000) (dn/dc)/l, where M is
the molecular mass, l the wavelength in cm (655610
27 cm) and
dn/dc the refractive index increment. A value of 0.185 cm
3/g was
assumed for dn/dc.
Sedimentation equilibrium experiments were conducted at
16.0uC on a Beckman Coulter ProteomeLab XL-I analytical
ultracentrifuge in ultracentrifugation buffer. 160 mL of each of the
samples at various concentrations were loaded into mechanically
aged 2-channel centerpiece cells [33] and analyzed at various rotor
speeds ranging from 14,000 to 35,000 rpm. Scans were collected
using the Rayleigh interference optical detection system at six-
hour intervals until sedimentation equilibrium was reached, as
determined by WinMATCH v0.99. Equilibrium was reached
within 54 hours, at which point the rotor speed was increased to
the next higher speed. Water blanks previously obtained for the
mechanically aged cells were subtracted from the experimental
data prior to analysis in SEDPHAT8.2 [34]. Various models,
including a species analysis and a monomer-dimer self-association,
with and without mass conservation, were used to analyze the
data. Time-independent (TI) noise corrections were implemented
when these did not correlate with the best-fit model [35]. Excellent
fits were obtained for data presented with interference root mean
square deviations values ranging from 0.003–0.005 fringes.
Experiments were carried out using long column lengths and
various rotor speeds. The long column lengths and meniscus
depletion were used in order to identify Max-E47 monomer, if
present, and discriminate between the smallest species and higher
order aggregates. Furthermore, the lowest rotor speeds were
designed to discriminate between the Max-E47 tetramer and
smaller mass complexes.
Circular Dichroism Spectroscopy
250 mL samples were prepared with 10 mM protein monomer
in 15.1 mM Na2HPO4, 4.9 mM KH2PO4, 50 mM NaCl, pH 7.4,
and 10 mM duplex DNA where appropriate (i.e. 1:2 ratio of
protein dimer:DNA duplex). For native MaxbHLHZ, the
temperature-leap tactic was used to ensured folded, functional
proteins for circular dichroism (CD) measurements [36]. Samples,
including the buffer control without protein, were prepared and
incubated overnight at 4uC, followed by approximately 20 min-
utes incubation at room temperature. For Max-E47, the protein
stock was stored in 20 mM Tris pH 8, 0.1 M NaCl, and an
equivalent amount of this storage buffer was added to the buffer
blank. Samples were incubated overnight at room temperature, as
aggregation had been observed at 4uC. CD data was collected on
an Aviv 215 spectrometer with a Suprasil, 1 mm path-length cell
(Hellma, Plainview, NY) at 22uC. Spectra were acquired between
190 and 300 nm at 0.2 nm increments and a sampling time of
0.2 seconds. Each spectrum was the average of two scans with the
average buffer (and DNA where appropriate) control spectrum
subtracted. Data obtained were not smoothed. Protein helix
content was calculated using the method described by Chau and
coworkers [37].
Results and Discussion
Structure of Max-E47
Crystals of Max-E47 grew at 4uC and reached their maximum
size in about three weeks. The crystals belong to the I212121 space
group, have low solvent content and diffract X-rays to 1.7 A ˚
resolution (Table 1). The structure was determined by molecular
replacement using the E47 monomer from the E47/NeuroD1
structure (PDB accession code: 2QL2, [16]) as searching model
and residues 7 to 68 could be readily traced in the electron density
maps.
The asymmetric unit of the crystal contains one monomer of
Max-E47, though a Max-E47 dimer forms by crystallographic
symmetry (Figure 1A, 1B). Despite the absence of its cognate DNA
target, the overall structure of Max-E47 is virtually identical to
those of other bHLH and bHLHZ dimers [13,15,16,38]. This
finding was somewhat unexpected because it had been previously
shown that addition of polyions, such as DNA, assists dimerization
and increases the structural organization of bHLH and bHLHZ
proteins [39]. However, the conformation of helix a1 is different
from that of other bHLHZ structures determined in the presence
of DNA (Figure 1).
In contrast to the structure of Max bound to DNA where the
basic region of helix a1 is straight, the corresponding region of
Max-E47 kinks at residue Arg16, thereby defining a concave inner
groove that effectively narrows the access to the DNA-binding
groove (Figure 1C). A kink in helix a1 is also present in the
structure of E47 bound to DNA; however, it occurs a turn earlier
(at residue Ala343) and should not interfere with DNA binding
(Figure 1C). The bending of the basic region of Max-E47 suggests
that DNA binding would force this region of the protein to flare
away from the symmetry axes in order to recognize the E-box. In a
simple analogy, the basic region of the Max-E47 may work like a
binder clip that must be opened in order to hold an E-box. While
we cannot rule out that crystal packing induces this conforma-
tional change, the basic region of Max-E47 does not engage in any
packing interactions and, hence, this possibility seems unlikely.
The helix-loop-helix region of Max-E47 is perfectly defined in
the electron density maps and defines the characteristic parallel,
left-handed four-helix bundle from this superfamily of transcrip-
tion factors (Figure 2A). Conversely, only the main chain of the
Crystal Structure of Max-E47
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chains show weak and fragmented electron density indicating their
flexibility in the absence of its DNA target (Figure 2B). Similar to
other structures of bHLH dimers, the loop connecting helices a1
and a2 is also more flexible than the rest of the protein, as
indicated by the quality of the electron density maps and the
higher B-factor values of this region (Figures 1A and 2B).
Max-E47 is a dimer in solution
Purified Max-E47 elutes from a size-exclusion column at a volume
consistent with the presence of a dimer (Figure 3A). Accordingly,
sedimentation velocity experiments revealed that Max-E47 is
predominantly dimeric in solution over a broad concentration range
(3–130 mM), although tetramers are also detected (Figure 3B).
Interestingly, tetramers have not been previously detected for E47
[40,41]. Sedimentation equilibrium data, modeled in terms of two
non-interacting species (the simplest model that fit the data), returned
molecular masses of 17.6 and 31.8 kDa indicating the presence of
both Max-E47 dimers and tetramers (Figure 3C). These species do
not appear to be in chemical equilibrium and simple mass
conservation constraints indicate that the tetramer represents
,17% of the total loading signal, thus confirming that Max-E47 is
predominantly dimeric in solution. There was no evidence for any
Max-E47 monomer, even at the highest rotor speeds.
The formation of functional bHLHZ tetramers was first
documented for the DNA binding domain of upstream stimulatory
factor (USF) [14] and later visualized in the structures of the Max
homodimer and the Myc/Max heterodimer [12,17]. Indeed, it has
been proposed that the functional unit of USF is the homo-
tetramer [14,24]. In the Myc/Max structure, the head-to-tail
association of the individual leucine zippers of each heterodimer
results in the formation of an antiparallel four-helix bundle
heterotetramer. However, formation of the Myc/Max hetero-
tetramer depends on the presence of the leucine zipper and can
only be supported by the heterodimer, as it is stabilized through
electrostatic interactions between the Max and Myc subunits in
adjacent heterodimers. Therefore, the Max-E47 homotetramer
detected by analytical ultracentrifugation is probably unrelated to
the heterotetramer formed by the Myc/Max complex. The
packing in the Max-E47 crystals reveals the presence of an
intimate dimer-of-dimers arrangement that occludes 1,760 A ˚ 2
Table 1. Data collection and refinement statistics.
Data Collection
Space group I212121
Cell Dimensions (A ˚, u) 37.48, 49.47, 74.1, 90, 90, 90
Wavelength (A ˚) 1.1
Resolution (A ˚)
a 40–1.7 (1.73–1.7)
Completeness (%)
a 99.7 (98.5)
Redundancy
a 8.9 (4.6)
Rmerge (%)
a 6.3 (64.7)
I/s(I)
a 32.1 (2.1)
Wilson B-value (A ˚2) 24.2
Solvent content 47%
Refinement
Resolution (A ˚) 23.3–1.7
Number of reflections (work/test) 7,197/353
Rwork/Rfree (%) 20.6/23.8
Number of atoms (protein/solvent) 514/34
R.m.s.d. bond length (A ˚) 0.003
R.m.s.d. bond angles (u) 0.567
Ramachandran Plot (%) (Favored/additional/
disallowed)
96.4/3.6/0
Maximum likelihood coordinate error 0.14
aData in the highest resolution shell are shown in parentheses.
doi:10.1371/journal.pone.0032136.t001
Figure 1. Structure of Max-E47. (A) Orthogonal views of the Max-E47 structure shown as a ribbon representation with one protomer colored as a
rainbow by B-factor (10 (blue)#B#70 (red)) and the other protomer shown with basic region from Max in blue and the helix-loop-helix region from
E47 in yellow. The inset highlights the bending of helix a1 in Max-E47 (blue-yellow) towards the symmetry axes of the dimer. The structures of
MaxbHLHZ (light blue) and E47bHLH (light yellow) are shown as a reference. (B) Sequence of the Max-E47 chimera with the basic regions from Max
and E47 colored as in panel (A). Sequences added during cloning are shaded in grey. The secondary structure elements are indicated above the
sequence, with the disordered regions shown as dashed lines. The native residues of Max and E47 are indicated underneath and the two mutations
that create the Max-E47Y and Max-E47YF cloning variants are marked with arrows. (C) Detail of the conformational changes in helix a1 induced by
DNA binding. From left to right: Max-E47 (Max and E47 portions colored in purple and pink, respectively), MaxbHLHZ bound to DNA (teal), E47bHLH
bound to DNA (yellow) and a superimposition of the three structures. The helical axes are indicated as grey lines beside each structure and kinks in
the helices are marked with black arrows.
doi:10.1371/journal.pone.0032136.g001
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occludes 3,120 A ˚ 2. Similar to the Myc/Max heterotetramer, the
two dimers associate in a head-to-tail fashion, and the surface is
stabilized by the interaction amongst the a2 helices of the two
dimers (Figure 4).
The Max-E47YF cloning variant, which possesses two point
mutations in the helix-loop-helix region of the protein (Max-E47-
V51Y/V59F [23]), also behaves primarily as a dimer in solution
(Figure 5A). In this case, sedimentation equilibrium data were best
fit in terms of a single species having a molecular mass of
18.860.3 kDa. Attempts to model these data in terms of a
reversible monomer-dimer equilibrium self-association returned a
Kd smaller than 1 nM and a 95% confidence upper limit of
30 nM. These data are consistent with the sole presence of dimers,
and unlike Max-E47, no evidence for tetramers was observed. In
this variant, Val51 and Val59 are mutated to Tyr and Phe,
respectively, a change that should presumably weaken the stability
of the dimer. The side chain of Val59 resides at the dimer interface
and, hence, substitution by a larger side chain forces the dimer
interface to breathe (Figure 5B). The effect of replacing Val51 by a
larger aromatic residue is less clear. Val51 sits atop the four-helix
bundle within a hydrophobic pocket defined by Cys29, His32 and
Leu33 from helix a1, and Ile52 and Leu55 from helix a2
(Figure 5C). Mutation of Val51 to Tyr should widen this pocket
and this, in turn, should destabilize the dimer. However, since
Max-E47-YF monomers were not detected by sedimentation
equilibrium under meniscus depletion conditions (Figure 5A), we
presume that the dimerization dissociation constant of Max-E47 is
likely in the low nanomolar range. Collectively, this data suggests
that Max-E47 could bind to its cognate DNA site as a dimer,
although we cannot rule out the possibility that Max-E47 exhibits
monomer-dimer equilibrium at concentrations below the detection
limits of our experiment.
The helical content of Max-E47 increases upon DNA
binding
It has been previously proposed that bZIP and bHLHZ
transcription factors exist in monomer-dimer equilibrium in
solution, and that the basic region is predominantly unstructured
in the absence of DNA. Upon binding of two bHLHZ monomers
to their cognate DNA target, folding of the basic regions is
triggered and dimerization is enhanced [39,41,42]. Supporting the
idea that DNA enhances the folding of the basic region, the
majority of bHLHZ crystal structures have been determined in the
presence of DNA [12,13,14,16,17]. The structure of the ATF4-
C/EBPb heterodimer, from the bZIP family of proteins, was
determined in the absence of DNA [43]. In this structure, the basic
region of ATF4 adopts a helical conformation while that of C/
EBPb is mostly disordered, reinforcing the idea that DNA
enhances, but does not govern helix formation. Despite the
absence of DNA, most of the basic region of Max-E47 adopts a
helical structure. Residues Ala5-Arg15 in the basic region of Max-
E47 are ordered in the crystal structure, though the side chains
deemed important for E-box recognition are poorly defined in the
electron density maps presumably due to their increased flexibility
(Figure 2). The fact that only the first turn of this helix (residues
Ala1–Arg4) is disordered suggests that binding to the E-box
promotes stability of the Max-E47 structure, but DNA binding is
not a requirement for induction of helical conformation in the
basic region.
To probe this idea, we assessed the secondary structural content
of Max-E47 in the presence or absence of DNA by circular
dichroism (Table 2 and Figure S1). In the absence of DNA, Max-
E47 helicity was 41% but underwent a modest folding transition
upon addition of DNA. Interestingly, the sequence of the DNA
had only a minor effect on the structure of Max-E47, as both E-
box and non-specific DNA caused similar increases in helicity (to
56% and 51%, respectively). This folding transition corresponds to
7–10 residues becoming ordered upon addition of DNA, a change
that can be correlated with the ordering of the N-terminal portion
of the basic region (Ala1–Arg4) in the two protomers of the dimer.
A similar trend was observed for native MaxbHLHZ, which was
49% helical in the absence of DNA, increasing to 66% in the
presence of non-specific DNA or 67% when its cognate E-box was
added. Therefore, addition of duplex DNA moderately increased
protein secondary structure of Max-E47 and MaxbHLHZ,
regardless of DNA sequence. Their specific DNA binding also
Figure 2. Electron density maps of Max-E47. Detailed view of the dimerization interface (A) and the basic region of Max-E47 (B). Composite
omit electron density maps contoured at 1.5s are shown as a white mesh. The two protomers of the Max-E47 dimer are shown as yellow and white
color-coded sticks.
doi:10.1371/journal.pone.0032136.g002
Crystal Structure of Max-E47
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Max-E47 display identical high-affinity Kd values with the E-box
(Table 2).
Folding transitions upon non-specific DNA binding have also
been observed for other native bHLH and bHLHZ proteins such
as MASH-1, Pho4, and the bHLHZ domain of USF
[14,18,44,45]. Based on steady state fluorescence analysis, a two-
step binding mechanism for DNA binding of USF where fast
association of the protein:DNA complex is followed by a slow
conformational rearrangement that could involve adjustment of
protein side chains to favor specific interactions with DNA was
proposed [24]. This DNA-binding mechanism could explain the
minimal differences in secondary structure observed for Max-E47
whether in the presence of non-specific or specific DNA (Table 2).
All bHLHZ proteins analyzed to date exhibit high-affinity binding
to sequence-specific DNA and, in some cases, even the dissociation
constants for nonspecific DNA are lower than the relatively high
protein concentrations required for CD spectroscopy (Kd values of
0.1–50 nM for protein:non-specific DNA complexes compared to
1–100 mM protein concentrations required for CD) [18,44,45].
Figure 3. Max-E47 is a dimer in solution. (A) Size exclusion chromatography profile of Max-E47 over a Superdex75 column (GE Healthcare). Max-
E47 elutes at a volume consistent with a dimer as reflected by the elution volumes of the molecular weight markers (albumin, 67 kDa; ovoalbumin,
43 kDa; chymotrypsinogen A, 25 kDa; and ribonuclease A, 13.7 kDa). (B) Continuous c(s) distributions obtained from sedimentation velocity data
collected at 50 krpm, for Max-E47 (left) in 20 mM Tris pH 8.0, 0.1 M NaCl, 10 mM 2-mercaptoethanol and 5% (v/v) glycerol at loading concentrations
of 3 (red), 22 (orange), 60 (green) and 130 (blue) mM. A major species is observed at 1.70 S representing a Max-E47 dimer, based on a best-fit
molecular mass of 17.760.3 kDa (Mcalc monomer=9.066 kDa) obtained for this species in the absence of glycerol. (C) Sedimentation equilibrium
profiles for Max-E47 at 16.0uC plotted as a distribution of the interference fringe displacement vs. radius at equilibrium. Data were collected at 14
(orange), 21 (yellow), 28 (green) and 35 (brown) krpm and loading concentrations of 25 (left panel), 10 (center panel) and 5 mM (right panel). The
solid lines show the best-fit analyses in terms of two non-interacting species, returning molecular masses of 17.6 and 31.8 kDa and indicating the
presence of both Max-E47 dimers and tetramers. The corresponding residuals for these best-fit analyses are shown in the plots above. Statistically
indistinguishable fits (within 90% confidence intervals) were obtained when data were modeled in terms of a mixture of non-interacting Max-E47
dimers and tetramers. In these cases corrections for the time-invariant noise were not carried out.
doi:10.1371/journal.pone.0032136.g003
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specific DNA up to 2 mM monomeric concentration by fluores-
cence anisotropy [23]. Unlike the fluorescence anisotropy studies,
the CD measurements were performed with 10 mM protein, lower
ionic strengths and the absence of competitors; it is, therefore,
possible that Max-E47 binds to nonspecific DNA under these
conditions.
Potential binding mechanisms of Max-E47 to DNA
Two distinct models have been proposed for recognition of the
E-box by bHLHZ proteins. Kohler et al. proposed that a monomer
pathway, described as sequential binding of monomers to DNA
followed by dimerization, would lead to enhanced specificity by
avoiding kinetic trapping of pre-formed dimers bound at non-
specific sites [42]. Meanwhile, Sha et al. proposed a two-step
binding mechanism characterized by the fast and unspecific
association of USF to DNA, followed by a slow conformational
rearrangement that could involve adjustment of protein side
chains to favor specific interactions with DNA [24]. We have not
been able to detect monomers of Max-E47 and, while we cannot
exclude that monomers exist at lower concentrations, our results
support that Max-E47 achieves DNA-binding specificity through
the latter two-step pathway. Supporting this mechanism, NMR
studies of Pho4 showed very little difference in secondary structure
and backbone dynamics of the basic region whether specific or
non-specific DNA was present [18]. These data suggest that Pho4
may bind DNA through favorable electrostatic interactions
between the negative DNA backbone and positive basic region,
thereby triggering helix formation in the basic region. Subsequent,
stable DNA binding is only achieved when specific side chains
within the basic region recognize their target DNA sequence. A
similar mechanism has been proposed for Max binding to DNA
[19,46]. Both Sauve et al. and Cohen et al. presented data
consistent with a pathway where rapid, weak protein:DNA
binding and formation of secondary structure are followed by
slower fine-tuning conformational change of the protein side
chains, upon location of the specific DNA target [18,24]. Thus, the
helical folding transition of Max-E47 measured by CD may reflect
the rapid association of Max-E47 with DNA rather than correlate
with specificity of DNA binding.
Conclusions
This work reveals that the Max-E47 chimera retains the
structural organization of the bHLH superfamily and has
oligomerization properties similar to E47. Our analytical ultra-
centrifugation studies show that Max-E47 behaves as a dimer even
at low micromolar loading concentrations and the modest
Figure 4. Oligomerization of the Max-E47 dimer. The crystal
packing of Max-E47 suggests that dimers of Max-E47 (shown as orange
and purple ribbon diagrams) can associate through crystallographic
symmetry to form tetramers.
doi:10.1371/journal.pone.0032136.g004
Figure 5. Max-E47YF is a monodisperse dimer in solution. (A) Sedimentation equilibrium profiles for Max-E47YF at 16.0uC plotted as a
distribution of the interference fringe displacement vs. radius at equilibrium. Data were collected at 14 (orange), 21 (yellow), 28 (green) and 35
(brown) krpm and loading concentrations of 20 (left panel), 10 (center panel) and 5 mM (right panel). The solid lines show the best-fit analyses in
terms of a single ideal solute with mass conservation constraints, returning a molecular mass of 18.860.3 kDa, and demonstrating that Max-E47YF is
a monodisperse dimer (Mcalc monomer=9.179 kDa). The corresponding residuals for this best-fit are shown in the plots above. The best-fit time-
invariant noise is also shown in each plot shifted by +1.9 (left), +1.6 (center) and +0.75 (right) fringes. Attempts to fit these data in terms of a MaxE47-
YF monomer-dimer self-association indicate dimerization affinities tighter than 1 nM with a 95% confidence upper limit of 30 nM. (B) Detailed view
of the 2Fo-Fc electron density map (contoured at 1 s) around Val59. (C) Detailed view of the 2Fo-Fc electron density map (contoured at 1 s) around
Val51.
doi:10.1371/journal.pone.0032136.g005
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32136conformational changes measured by circular dichroism suggest
that Max-E47 may target its intended E-box site by a pathway
similar to that exhibited by bHLHZ proteins such as Max, Pho4
and USF. Collectively, these results reveal that this non-native,
engineered protein chimera designed by fusing the basic region of
Max and the HLH region of E47 behaves both structurally and
functionally like its native counterparts, thereby providing a
molecular tool to modulate the Myc/Max/Mad network.
Supporting Information
Figure S1 Circular dichroism. Spectra of (A) Max-E47 and
(B) MaxbHLHZ in the absence of DNA (green), with nonspecific
DNA (red), or Max E-box DNA (blue). DNA sequences are given
in Table 2. Samples contained 10 mM protein monomer and
10 mM DNA where appropriate. Each spectrum was averaged
twice, and curves were not subjected to smoothing. The buffer
control was subtracted from each protein spectrum. Mean residue
ellipticities are presented, which account for differences in lengths
of proteins.
(TIF)
Acknowledgments
We thank Tom Ellenberger for providing the coordinates of the E47
homodimer bound to DNA and Yu Seon Chung for helpful discussions.
Author Contributions
Conceived and designed the experiments: RG JAS AG. Performed the
experiments: FA RG ADJ MG. Analyzed the data: FA RG ADJ JAS AG.
Contributed reagents/materials/analysis tools: FA RG ADJ MG JAS AG.
Wrote the paper: RG JAS AG.
References
1. Atchley WR, Fitch WM (1997) A natural classification of the basic helix-loop-
helix class of transcription factors. Proc Natl Acad Sci U S A 94: 5172–5176.
2. Ephrussi A, Church GM, Tonegawa S, Gilbert W (1985) B lineage–specific
interactions of an immunoglobulin enhancer with cellular factors in vivo.
Science 227: 134–140.
3. Massari ME, Murre C (2000) Helix-loop-helix proteins: regulators of
transcription in eucaryotic organisms. Mol Cell Biol 20: 429–440.
4. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ (2005) Cancer therapeutics:
targeting the dark side of Myc. Eur J Cancer 41: 2485–2501.
5. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein
that forms a sequence-specific DNA-binding complex with Myc. Science 251:
1211–1217.
6. Blackwood EM, Kretzner L, Eisenman RN (1992) Myc and Max function as a
nucleoprotein complex. Curr Opin Genet Dev 2: 227–235.
7. Prendergast GC, Lawe D, Ziff EB (1991) Association of Myn, the murine
homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and
ras cotransformation. Cell 65: 395–407.
8. Hurlin PJ, Ayer DE, Grandori C, Eisenman RN (1994) The Max transcription
factor network: involvement of Mad in differentiation and an approach to
identification of target genes. Cold Spring Harb Symp Quant Biol 59: 109–116.
9. Larsson LG, Bahram F, Burkhardt H, Luscher B (1997) Analysis of the DNA-
binding activities of Myc/Max/Mad network complexes during induced differen-
tiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene 15: 737–748.
10. Larsson LG, Pettersson M, Oberg F, Nilsson K, Luscher B (1994) Expression of
mad, mxi1, max and c-myc during induced differentiation of hematopoietic
cells: opposite regulation of mad and c-myc. Oncogene 9: 1247–1252.
11. McArthur GA, Laherty CD, Queva C, Hurlin PJ, Loo L, et al. (1998) The Mad
protein family links transcriptional repression to cell differentiation. Cold Spring
Harb Symp Quant Biol 63: 423–433.
12. Brownlie P, Ceska T, Lamers M, Romier C, Stier G, et al. (1997) The crystal
structure of an intact human Max-DNA complex: new insights into mechanisms
of transcriptional control. Structure 5: 509–520.
13. Ellenberger T, Fass D, Arnaud M, Harrison SC (1994) Crystal structure of
transcription factor E47: E-box recognition by a basic region helix-loop-helix
dimer. Genes Dev 8: 970–980.
14. Ferre-D’Amare AR, Pognonec P, Roeder RG, Burley SK (1994) Structure and
function of the b/HLH/Z domain of USF. EMBO J 13: 180–189.
15. Ferre-D’Amare AR, Prendergast GC, Ziff EB, Burley SK (1993) Recognition by
Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363:
38–45.
16. Longo A, Guanga GP, Rose RB (2008) Crystal structure of E47-NeuroD1/beta2
bHLH domain-DNA complex: heterodimer selectivity and DNA recognition.
Biochemistry 47: 218–229.
17. Nair SK, Burley SK (2003) X-ray structures of Myc-Max and Mad-Max
recognizing DNA. Molecular bases of regulation by proto-oncogenic transcrip-
tion factors. Cell 112: 193–205.
18. Cave JW, Kremer W, Wemmer DE (2000) Backbone dynamics of sequence
specific recognition and binding by the yeast Pho4 bHLH domain probed by
NMR. Protein Sci 9: 2354–2365.
19. Sauve S, Naud JF, Lavigne P (2007) The mechanism of discrimination between
cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
J Mol Biol 365: 1163–1175.
20. Luscher B (2001) Function and regulation of the transcription factors of the
Myc/Max/Mad network. Gene 277: 1–14.
21. Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G, et al. (1998)
Design and properties of a Myc derivative that efficiently homodimerizes.
Oncogene 17: 2463–2472.
22. Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, et al. (2008)
Modelling Myc inhibition as a cancer therapy. Nature 455: 679–683.
23. Xu J, Chen G, De Jong AT, Shahravan SH, Shin JA (2009) Max-E47, a
designed minimalist protein that targets the E-box DNA site in vivo and in vitro.
J Am Chem Soc 131: 7839–7848.
24. Sha M, Ferre-D’Amare AR, Burley SK, Goss DJ (1995) Anti-cooperative
biphasic equilibrium binding of transcription factor upstream stimulatory factor
to its cognate DNA monitored by protein fluorescence changes. J Biol Chem
270: 19325–19329.
25. Otwinowski Z, Minor W (1997) Processing of X-ray Diffraction Data Collected
in Oscillation Mode. In: Carter CW, Sweeet RM, eds. Methods in Enzymology.
New York: Academic Press. pp 307–326.
26. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al.
(2007) Phaser crystallographic software. J Appl Crystallogr 40: 658–674.
27. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
28. Afonine PV, Grosse-Kunstleve RW, Adams PD (2005) phenix.refine. CCP4
Newsletter 42: contribution 8.
29. Lovell SC, Davis IW, Arendall WB, 3rd, de Bakker PI, Word JM, et al. (2003)
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins
50: 437–450.
30. Collaborative Computational Project N (1994) The CCP4 suite: programs for
protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–763.
Table 2. Circular dichroism and DNA binding affinities.
Protein % Helicity % Helicity (with NS DNA
a) % Helicity (with E-Box
b)K d (nM) with E-Box
b
Max 49 66 67 14.367.9
c
Max-E47 41 51 56 15.361.6
c
E47
d 50 — 80 —
aNS DNA is non-specific DNA (59-TGCAGGAATTCCAAGGTGAAGGTT);
bE-box DNA used in CD is 59-TGCAGGAACCACGTGGTGAAGGTT. For previously published Kd values obtained by fluorescence anisotropy, the same DNA sequence was
used, except that the forward oligonucleotide was labeled at the 59 end with 6-carboxyfluorescein (6-FAM);
cfrom [23];
dfrom [41]. Note that our CD data is presented for 10 mM monomeric protein concentrations, whereas Wendt et al. used 20 mM E47 monomer [41].
doi:10.1371/journal.pone.0032136.t002
Crystal Structure of Max-E47
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e3213631. Schuck P (2000) Size-distribution analysis of macromolecules by sedimentation
velocity ultracentrifugation and lamm equation modeling. Biophys J 78:
1606–1619.
32. Cole JL, Lary JW, T PM, Laue TM (2008) Analytical ultracentrifugation:
sedimentation velocity and sedimentation equilibrium. Methods Cell Biol 84:
143–179.
33. Balbo A, Schuck P (2005) Analytical ultracentrifugation in the study of protein
self-association and heterogenous protein-protein interactions: Protocols for
velocity and equilibrium sedimentation. In: Golemis E, Adams PD, eds. Protein-
Protein Interactions – A molecular cloning manual. New York: Cold Spring
Harbor Laboratory Press.
34. Lebowitz J, Lewis MS, Schuck P (2002) Modern analytical ultracentrifugation in
protein science: a tutorial review. Protein Sci 11: 2067–2079.
35. Vistica J, Dam J, Balbo A, Yikilmaz E, Mariuzza RA, et al. (2004) Sedimentation
equilibrium analysis of protein interactions with global implicit mass conserva-
tion constraints and systematic noise decomposition. Anal Biochem 326:
234–256.
36. Bird GH, Lajmi AR, Shin JA (2002) Manipulation of temperature to improve
solubility of hydrophobic proteins and cocrystallization with matrix for analysis
by MALDI-TOF mass spectrometry. Anal Chem 74: 219–225.
37. Chen YH, Yang JT, Chau KH (1974) Determination of the helix and beta form
of proteins in aqueous solution by circular dichroism. Biochemistry 13:
3350–3359.
38. Ma PC, Rould MA, Weintraub H, Pabo CO (1994) Crystal structure of MyoD
bHLH domain-DNA complex: perspectives on DNA recognition and implica-
tions for transcriptional activation. Cell 77: 451–459.
39. Banerjee A, Hu J, Goss DJ (2006) Thermodynamics of protein-protein
interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
Biochemistry 45: 2333–2338.
40. Fairman R, Beran-Steed RK, Handel TM (1997) Heteronuclear (1H, 13C, 15N)
NMR assignments and secondary structure of the basic region-helix-loop-helix
domain of E47. Protein Sci 6: 175–184.
41. Wendt H, Thomas RM, Ellenberger T (1998) DNA-mediated folding and
assembly of MyoD-E47 heterodimers. J Biol Chem 273: 5735–5743.
42. Kohler JJ, Metallo SJ, Schneider TL, Schepartz A (1999) DNA specificity
enhanced by sequential binding of protein monomers. Proc Natl Acad Sci U S A
96: 11735–11739.
43. Podust LM, Krezel AM, Kim Y (2001) Crystal structure of the CCAAT box/
enhancer-binding protein beta activating transcription factor-4 basic leucine
zipper heterodimer in the absence of DNA. J Biol Chem 276: 505–513.
44. Kunne AG, Sieber M, Meierhans D, Allemann RK (1998) Thermodynamics of
the DNA binding reaction of transcription factor MASH-1. Biochemistry 37:
4217–4223.
45. Meierhans D, el-Ariss C, Neuenschwander M, Sieber M, Stackhouse JF, et al.
(1995) DNA binding specificity of the basic-helix-loop-helix protein MASH-1.
Biochemistry 34: 11026–11036.
46. Cohen SL, Ferre-D’Amare AR, Burley SK, Chait BT (1995) Probing the
solution structure of the DNA-binding protein Max by a combination of
proteolysis and mass spectrometry. Protein Sci 4: 1088–1099.
Crystal Structure of Max-E47
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e32136